AIDSmeds.com provides updated treatment information to people with HIV and AIDS. The website’s mission is to help patients make informed decisions about their treatment plans. AIDSmeds has a comprehensive list of treatments for HIV/AIDS, opportunistic infections, and side effects. The website also provides prevention information and advice for those who have been newly diagnosed.

Aptivus (tipranavir) belongs to a class of anti-HIV drugs known as protease inhibitors, which are known to reduce the amount of HIV in the blood and to increase the number of CD4 cells in the body. Aptivus must always be taken with Norvir (ritonavir). At least two other antiretroviral drugs must be used with Aptivus plus Norvir.

Atripla (efavirenz/emtricitabine/tenofovir) includes an entire HIV regimen in a once-daily pill. It is a combination of three different antiretroviral drugs, which in combination have been proven to lower viral loads and increase CD4 cell counts.

Combivir (zidovudine/lamivudine) belongs to a class of anti-HIV drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs act as fake versions of the building blocks HIV needs to replicate, preventing HIV from making copies of itself. Combivir comes as a tablet and is usually taken twice a day.

Crixivan (indinavir) belongs to a class of anti-HIV drugs known as protease inhibitors, which are known to reduce the amount of HIV in the blood and to increase the number of CD4 (white blood) cells in the body.

AIDSinfo is a website maintained by the U.S. Department of Health and Human Services (HHS). Its purpose is to bring federal information regarding HIV and AIDS research, treatments, prevention, and medical practices to the public. This website specifically focuses on clinical research information and medical guidelines as related to the care of people with HIV and AIDS.

Didanosine (Videx) belongs to a class of anti-HIV drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs act as fake versions of the building blocks HIV needs, preventing HIV from making copies of itself. Didanosine comes in the form of a slow-release capsule and a powder that is dissolved in water.

Emtriva (emtricitabine) belongs to class of anti-HIV drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs act as fake versions of the building blocks HIV needs to replicate, preventing HIV from making copies of itself.

Epivir (lamivudine) belongs to class of anti-HIV drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs act as fake versions of the building blocks HIV needs, preventing HIV from making copies of itself. Epivir is always combined with other anti-HIV drugs. It is an ingredient in Combivir (zidovudine/lamivudine), Trizivir (zidovudine/lamivudine/abacavir), and Epzicom (abacavir/lamivudine). Epivir is not usually effective for people who have already taken Emtriva (emtricitabine) and developed resistance to it.

Epzicom (abacavir/lamivudine) is a combination pill containing two anti-HIV drugs in the class known as nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs act as fake versions of the building blocks HIV needs, preventing HIV from making copies of itself. Epzicom is taken once a day.